REGULATED PRESS RELEASE published on 05/21/2025 at 14:05, 7 months 22 days ago GUILLEMOT CORPORATION : Informations relatives au nombre total de droits de vote et d’actions 30/04/2025 Guillemot Corporation S.A. reports total number of voting rights and shares on April 30, 2025 as 14,687,480 shares and 24,490,891 theoretical voting rights. The company designs and manufactures interactive leisure hardware and accessories under Hercules and Thrustmaster brands Voting Rights Shares Guillemot Corporation Thrustmaster Interactive Leisure Hardware
PRESS RELEASE published on 05/21/2025 at 14:00, 7 months 22 days ago Galimedix Therapeutics publishes new data in peer-reviewed International Journal of Molecular Sciences demonstrating disease-modifying capability of GAL-201 in Alzheimer’s disease Galimedix Therapeutics publishes new data in peer-reviewed International Journal of Molecular Sciences demonstrating disease-modifying capability of GAL-201 in Alzheimer’s disease GAL-201 Galimedix Therapeutics Alzheimer’s Disease International Journal Of Molecular Sciences Neuroprotective Therapy
PRESS RELEASE published on 05/21/2025 at 14:00, 7 months 22 days ago Northern Data AG holds Annual General Meeting Northern Data AG successfully concluded its 2025 Annual General Meeting with shareholder approval of proposed resolutions. The meeting was broadcast via livestream Annual General Meeting Shareholder Approval Northern Data AG HPC Solutions Livestream
PRESS RELEASE published on 05/21/2025 at 14:00, 7 months 22 days ago SLAM Announces Flow-Through Private Placement SLAM Exploration Ltd. announces non-brokered private placement offering of flow-through units to raise funds for exploration in New Brunswick, Canada Private Placement Exploration New Brunswick Flow-through Units SLAM Exploration Ltd.
PRESS RELEASE published on 05/21/2025 at 14:00, 7 months 22 days ago Jaguar Health Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Jaguar Health, Inc. announces purchase of 246,306 shares of common stock at $6.09 per share in a registered direct offering. H.C. Wainwright & Co. serves as exclusive placement agent Shares Stock Purchase Jaguar Health H.C. Wainwright & Co. Direct Offering
PRESS RELEASE published on 05/21/2025 at 14:00, 7 months 22 days ago Troy Minerals Reports Ongoing Geophysical Studies at the Lake Owen Project, Wyoming Troy Minerals reports positive results from the geophysical survey at Lake Owen Project showing potential for vanadium, titanium, PGE, and other critical minerals Geophysical Survey Vanadium Troy Minerals Lake Owen Project Titanium
PRESS RELEASE published on 05/21/2025 at 14:00, 7 months 22 days ago Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ's In Response To Additional Shareholder Questions Interactive Strength Inc. (Nasdaq:TRNR) updates investor FAQs regarding upcoming AGM date and acquisitions. Check TRNR's investor presentation for further details Acquisitions Investor Presentation Interactive Strength Inc. Investor FAQs AGM Date
PRESS RELEASE published on 05/21/2025 at 13:31, 7 months 22 days ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research increases price target for Valneva SE to €8.10 following strong Q1/25 results and positive outlook on Lyme disease vaccine candidate, VLA15 First Berlin Equity Research Price Target Valneva SE Lyme Disease Vaccine Q1/25 Results
PRESS RELEASE published on 05/21/2025 at 13:30, 7 months 22 days ago Hardman & Co publication on ICG Enterprise Trust plc (ICGT): Investing in resilience, delivering growth Hardman & Co Research provides insights on ICG Enterprise Trust plc's resilience and growth strategy in their latest publication. Details on FY'25 results and investment highlights Investment Growth Hardman & Co Résilience ICG Enterprise Trust Plc
PRESS RELEASE published on 05/21/2025 at 13:05, 7 months 22 days ago Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2025 Protagonist Therapeutics to present at Jefferies Global Healthcare Conference on June 4, 2025. Learn about company overview and pipeline drug candidates Biopharmaceutical Company Clinical Studies Protagonist Therapeutics Jefferies Global Healthcare Conference Pipeline Drug Candidates
Published on 01/13/2026 at 01:10, 1 hour 3 minutes ago Clean Air Metals Announces 2026 Strategic Objectives in Historically Strong PGE and Copper Markets
Published on 01/13/2026 at 01:00, 1 hour 13 minutes ago CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026
Published on 01/12/2026 at 23:00, 3 hours 13 minutes ago Usha Resources Non-Brokered Private Placement of Convertible Debentures
Published on 01/12/2026 at 21:33, 4 hours 40 minutes ago Chesapeake Gold Announces Upsize of Previously Announced Bought Deal Public Offering to $15 Million and Non-Brokered Private Placement With Participation by Eric Sprott
Published on 01/12/2026 at 23:07, 3 hours 6 minutes ago US federal court grants preliminary injunction allowing Revolution Wind construction to resume
Published on 01/12/2026 at 22:02, 4 hours 10 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM confirms being in advanced discussions on the potential sale of certain businesses as part of its previously communicated deleveraging plan
Published on 01/12/2026 at 22:02, 4 hours 11 minutes ago ams OSRAM confirms being in advanced discussions on the potential sale of certain businesses as part of its previously communicated deleveraging plan
Published on 01/12/2026 at 20:31, 5 hours 42 minutes ago Symrise AG Announces Inaugural Share Buy-back Program
Published on 01/12/2026 at 20:07, 6 hours 6 minutes ago EQS-Adhoc: Symrise AG resolves a share buy-back program in the amount of EUR 400 million
Published on 01/12/2026 at 19:06, 7 hours 6 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of December 31, 2025
Published on 01/12/2026 at 19:06, 7 hours 6 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 décembre 2025
Published on 01/12/2026 at 18:28, 7 hours 45 minutes ago Thales - Half year liquidity contract statement on 31 December 2025
Published on 01/12/2026 at 18:28, 7 hours 45 minutes ago Thales - Bilan semestriel du contrat de liquidité au 31 décembre 2025
Published on 01/12/2026 at 18:15, 7 hours 58 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 12/31/2025